DeepMed Research

CL AVIATION, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors

Not Applicable

Withdrawn

Conditions: Metastatic Non-Small Cell Lung Cancer
Metastatic Colon Cancer
Metastatic Triple Negative Breast Cancer

Interventions: Drug: CTLA-4 Antibody
Radiation: Hypofractionated Radiotherapy

First Posted Date: 2013-09-06

Last Posted Date: 2017-06-27

Lead Sponsor: Western Regional Medical Center

Registration Number: NCT01936961

Locations: 🇺🇸
Western Regional Medical Center, Goodyear, Arizona, United States

Capecitabine With Digoxin for Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Metastatic Breast Cancer

Interventions: Drug: Capecitabine
Drug: Digoxin

First Posted Date: 2013-06-26

Last Posted Date: 2018-02-22

Lead Sponsor: Western Regional Medical Center

Target Recruit Count: 16

Registration Number: NCT01887288

Locations: 🇺🇸
Western Regional Medical Center, Goodyear, Arizona, United States

Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer

Phase 2

Terminated

Conditions: Squamous Cell Non-Metastatic Non-Small Cell Lung Cancer
Non-squamous Cell Non-Metastatic Non-Small Cell Lung Cancer

Interventions: Drug: Cisplatin
Drug: Gemcitabine
Drug: Pemetrexed

First Posted Date: 2013-05-22

Last Posted Date: 2018-02-07

Lead Sponsor: Western Regional Medical Center

Target Recruit Count: 1

Registration Number: NCT01860040

Locations: 🇺🇸
Western Regional Medical Center, Goodyear, Arizona, United States

Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

Phase 2

Terminated

Conditions: Pancreatic Carcinoma Non-resectable
Stage IV Pancreatic Cancer

Interventions: Drug: Gemcitabine
Drug: nab-Paclitaxel

First Posted Date: 2013-05-10

Last Posted Date: 2018-02-07

Lead Sponsor: Western Regional Medical Center

Target Recruit Count: 15

Registration Number: NCT01851174

Locations: 🇺🇸
Western Regional Medical Center, Goodyear, Arizona, United States

Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma

Phase 2

Withdrawn

Conditions: Metastatic Melanoma

Interventions: Drug: Cyclophosphamide and Interleukin 2

First Posted Date: 2013-04-17

Last Posted Date: 2017-08-24

Lead Sponsor: Western Regional Medical Center

Registration Number: NCT01833767

Locations: 🇺🇸
Western Regional Medical Center Inc, Goodyear, Arizona, United States

Interleukin-2 in Metastatic Kidney Cancer

Phase 2

Terminated

Conditions: Renal Cell Cancer Metastatic
Kidney Cancer Metastatic

Interventions: Drug: Interleukin-2

First Posted Date: 2012-10-10

Last Posted Date: 2018-02-08

Lead Sponsor: Western Regional Medical Center

Target Recruit Count: 7

Registration Number: NCT01702909

Locations: 🇺🇸
Western Regional Medical Center, Inc, Goodyear, Arizona, United States

Interleukin-2 in Metastatic Melanoma

Phase 2

Terminated

Conditions: Melanoma Metastatic

Interventions: Drug: Interleukin-2

First Posted Date: 2012-10-10

Last Posted Date: 2018-04-05

Lead Sponsor: Western Regional Medical Center

Target Recruit Count: 8

Registration Number: NCT01702896

Locations: 🇺🇸
Western Regional Medical Center, Inc., Goodyear, Arizona, United States

Dacarbazine and Carmustine in Metastatic Melanoma

Phase 2

Terminated

Conditions: Melanoma Metastatic

Interventions: Drug: Dacarbazine
Drug: Carmustine
Drug: Neulasta

First Posted Date: 2012-09-25

Last Posted Date: 2018-04-04

Lead Sponsor: Western Regional Medical Center

Target Recruit Count: 1

Registration Number: NCT01692691

Locations: 🇺🇸
Western Regional Medical Center, Goodyear, Arizona, United States

5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer

Phase 2

Completed

Conditions: Gastrointestinal Cancer Metastatic
Renal Cell Cancer Metastatic
Non Small Cell Lung Cancer Metastatic

Interventions: Drug: 5-Fluorouracil and Interferon

First Posted Date: 2012-08-07

Last Posted Date: 2018-03-21

Lead Sponsor: Western Regional Medical Center

Target Recruit Count: 18

Registration Number: NCT01658813

Locations: 🇺🇸
Western Regional Medical Center, Inc, Goodyear, Arizona, United States

Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)

Phase 1

Terminated

Conditions: Metastatic Adenocarcinoma of the Pancreas

Interventions: Drug: Gemcitabine, Intravenous and oral Ascorbic Acid (Vitamin C)

First Posted Date: 2012-08-01

Last Posted Date: 2018-07-26

Lead Sponsor: Eastern Regional Medical Center

Target Recruit Count: 3

Registration Number: NCT01654861

Locations: 🇺🇸
Eastern Regional Medical Center, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy